Latest News
Bayer receives FDA approval for AMBELVIST MRI contrast agent
15 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Monday that it has received US Food and Drug Administration (FDA) approval for AMBELVIST (gadoquatrane), an intravenous macrocyclic gadolinium-base...
Johnson & Johnson commits over USD1bn to expand Vision manufacturing in Jacksonville
15 June 2026 - Healthcare products company Johnson & Johnson (NYSE:JNJ) on Monday announced an investment of more than USD1bn to strengthen its Vision operations in Jacksonville, Florida, expanding US-based manufacturing, packaging, and distribut...
Genmab reports strong epcoritamab results in elderly newly diagnosed DLBCL patients
15 June 2026 - Danish biotechnology company Genmab A/S (CPH:GMAB) on Monday reported data from the Phase 2 EPCORE DLBCL-3 and Phase 1b/2 EPCORE NHL-2 studies showing high response rates for epcoritamab-based treatments in elderly patients with newly ...
AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer
...
Acousia Therapeutics reports positive top-line efficacy results for ACOU085 in cisplatin-induced ototoxicity
15 June 2026 - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced on Friday positive top-line efficacy results from its completed Phase 2a PROHEAR Study.ACOU...